McKesson Corporation (MCK)
Compared to Estimates, McKesson (MCK) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
McKesson (MCK) Surpasses Q4 Earnings Estimates
McKesson (MCK) came out with quarterly earnings of $11.69 per share, beating the Zacks Consensus Estimate of $11.56 per share. This compares to earnings of $10.12 per share a year ago.
Should You Buy, Sell, or Hold McKesson Before Q4 Earnings?
MCK heads into Q4 earnings with strength in oncology, GLP-1 demand, and biopharma services, but softer medical-surgical trends may weigh.
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) Falls More Steeply Than Broader Market: What Investors Need to Know
McKesson (MCK) closed the most recent trading day at $822.63, moving 1.48% from the previous trading session.
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading day saw McKesson (MCK) settling at $842.25, representing a -1.95% change from its previous close.
Is McKesson Stock Still A High-Conviction Compounder?
McKesson's net earnings increased at an average rate of 14.4% over the previous three years, while its earnings per share (EPS) grew by 19.6% annually in that same period. This 5.2% disparity indicates the additional value management has successfully secured for shareholders through a steadfast approach.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
McKesson (MCK) Advances But Underperforms Market: Key Facts
The latest trading day saw McKesson (MCK) settling at $871.18, representing a +1.7% change from its previous close.
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
